DEADLINE ALERT for SSRM, AGL, CC, SHLS: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
May 14, 2024 16:22 ET
|
Law Offices of Howard G. Smith
BENSALEM, Pa., May 14, 2024 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded...
CVR Energy Provides Update to Operational Statistics and Financial Information for its Petroleum and Renewables Businesses
May 14, 2024 16:19 ET
|
CVR Energy, Inc.
SUGAR LAND, Texas, May 14, 2024 (GLOBE NEWSWIRE) -- CVR Energy, Inc. (“CVR Energy” or the “Company”) (NYSE: CVI) today announced its outlook for certain operational statistics and financial...
Evoke Pharma Reports First Quarter 2024 Financial Results
May 14, 2024 16:15 ET
|
Evoke Pharma, Inc.
114% year-over-year increase in net product sales70% prescriber growth in Q1 2024 compared to Q4 2023Growing sales metrics reaffirms company’s $14M net revenue guidance for 2024 SOLANA BEACH, Calif.,...
Travel + Leisure Chooses Piedmont’s 501 W. Church Building in Downtown Orlando for New Headquarters Location
May 14, 2024 16:15 ET
|
Piedmont Office Realty Trust, Inc.
Atlanta, May 14, 2024 (GLOBE NEWSWIRE) -- Piedmont Office Realty Trust, Inc. ("Piedmont") (NYSE:PDM), an owner of Class A office properties located primarily in the Sunbelt, and the largest owner of...
DHT Holdings, Inc. First Quarter 2024 Results
May 14, 2024 16:15 ET
|
DHT Holdings, Inc.
HAMILTON, BERMUDA, May 14, 2024 – DHT Holdings, Inc. (NYSE:DHT) (“DHT” or the “Company”) today announced its results for the quarter ended March 31, 2024. The full report is available here and in...
Stryve Foods, Inc. Reports Fiscal 2024 First Quarter Results
May 14, 2024 16:15 ET
|
Stryve Foods, Inc.
Stryve Foods, Inc. Reports Fiscal 2024 First Quarter Results
NANOBIOTIX annonce l'acceptation par l'Agence américaine du médicament, la FDA, d'un protocole pour une nouvelle étude randomisée de Phase 2 évaluant NBTXR3 pour les patients atteints d'un cancer du poumon de stade trois
May 14, 2024 16:15 ET
|
Nanobiotix S.A.
PARIS et CAMBRIDGE, Mass., 14 mai 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société »), société française de biotechnologie en phase de développement clinique...
Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the European Hematology Association (EHA) 2024 Congress
May 14, 2024 16:15 ET
|
Shattuck Labs, Inc.
– Observed encouraging complete response (CR) rates as of the February 1, 2024, data cutoff in previously untreated HR-MDS and TP53m AML patients; successfully bridged responding TP53m AML patients to...
Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 14, 2024 16:15 ET
|
Vincerx Pharma, Inc.
Vincerx continued to progress Phase 1 dose-escalation studies for VIP943, a potentially best-in-class anti-CD123 antibody-drug conjugate (ADC), and VIP236, a first-in-class small molecule-drug...
AMD Announces Upcoming Events for the Financial Community
May 14, 2024 16:15 ET
|
Advanced Micro Devices, Inc.
SANTA CLARA, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Today, AMD (NASDAQ: AMD) announced the following events for the financial community: Jean Hu, executive vice president, chief financial officer...